Health innovation in developing countries to address diseases of the poor
Americanae (AECID Library)Published 15 July 2005Open access
Carlos Morel, Denis Broun, Ajit Dangi, Christopher Elias, C. A. Gardner, Gupta Rk
Citations40
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The formation of an Initiative for Health Product Innovation in Developing Countries is called for to accelerate the translation of new knowledge into health innovations relevant to the diseases of the poor and to economic growth, tak‐ing into account national priorities and sensitivities.
Abstract
Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil.
Keywords
MedicineBusiness, Management and AccountingEngineering
Nature GeneticsTop ten biotechnologies for improving health in developing countries
351 Citations2002Abdallah S. Daar, Halla Thorsteinsdóttir +4 more
An international group of eminent scientists with expertise in global health issues was asked to identify the top ten biotechnologies for improving health in developing countries, and the results offer concrete guidance to those in a position to influence the direction of research and development.
Parasitology TodayReaching Maturity — 25 Years of the TDR
121 Citations2000Chantal Morel
A new strategic vision is now being implemented by TDR that aims at a closer interaction with health systems and disease control programmes, capacity strengthening based on selected research initiatives and full exploitation of scientific and technological advances in the biomedical, social and information sciences.
PubMedInternational collaboration in health research.
15 Citations2005Adetokunbo O. Lucas
The study by Swingler et al. indicates that a high proportion of collaborative projects researched im-portant health problems in the region and that foreign sponsorship did not divert scientists in African countries from their priority health problems, though the paper raises some concerns.
ScienceAn Uncertain Call to Arms
4 Citations2004Claire M. Fraser
A recent special issue of Science described the scientific, economic, and political complexities of the drug discovery process that are driving pharmaceutical companies away from the development of antimicrobials and vaccines.